Douglas G. Cole

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael LaCascia, Attorney-in-Fact for Douglas G. Cole
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Douglas G. Cole

Form 4 holding Director

Denali Therapeutics Inc.

Security class
Common Stock
Shares / value
26,564
Estimated value
$489,309
Report date
01 Jun 2023
Price
$18.42
Ownership
Direct
Form 4 holding Director

Foghorn Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
25,000
Estimated value
$119,750
Report date
17 Jun 2025
Price
$4.79
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Sana Biotechnology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
65,000
Estimated value
Report date
06 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Denali Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
12,649
Estimated value
Report date
01 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Sigilon Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
$0.7500
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Douglas G. Cole

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .